Which cyclic antidepressants are superior for the treatment of depressed psoriatic patients? A theoretical molecular approach.
Namazi
M R
MR
D000929:Antidepressive Agents, Tricyclic / Q000494:pharmacology*; D049109:Cell Proliferation; D003863:Depression / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D015603:Keratinocytes / Q000378:metabolism; D008214:Lymphocytes / Q000378:metabolism; D008264:Macrophages / Q000378:metabolism; D011565:Psoriasis / Q000276:immunology*; D043587:Receptor, Muscarinic M3 / Q000187:drug effects / Q000378:metabolism; D018342:Receptors, Adrenergic, beta-1 / Q000187:drug effects / Q000378:metabolism
D000929:Antidepressive Agents, Tricyclic; D043587:Receptor, Muscarinic M3; D018342:Receptors, Adrenergic, beta-1